Trump’s recent nomination of White House health policy aide Dr. Heidi Overton as FDA commissioner has shifted focus to Senate confirmation proceedings. Announced August 19, the pick follows Marty Makary’s May resignation and aims to advance administration priorities on drug pricing, innovation, and “Make America Healthy Again” initiatives under HHS Secretary Robert F. Kennedy Jr. Key Senate Health Committee Chairman Bill Cassidy has raised immediate concerns over Overton’s involvement in a recent executive order on childhood vaccines, signaling potential hurdles in hearings and floor votes. Confirmation requires majority support in a Republican-led Senate, with procedural steps including committee review likely determining the timeline and outcome.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено30 сентября
62%
31 октября
52%
30 ноября
68%
31 декабря
73%
$1,485 Объем
30 сентября
62%
31 октября
52%
30 ноября
68%
31 декабря
73%
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Открытие рынка: Aug 20, 2026, 5:43 PM ET
Resolver
0x65070BE91...If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Trump’s recent nomination of White House health policy aide Dr. Heidi Overton as FDA commissioner has shifted focus to Senate confirmation proceedings. Announced August 19, the pick follows Marty Makary’s May resignation and aims to advance administration priorities on drug pricing, innovation, and “Make America Healthy Again” initiatives under HHS Secretary Robert F. Kennedy Jr. Key Senate Health Committee Chairman Bill Cassidy has raised immediate concerns over Overton’s involvement in a recent executive order on childhood vaccines, signaling potential hurdles in hearings and floor votes. Confirmation requires majority support in a Republican-led Senate, with procedural steps including committee review likely determining the timeline and outcome.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено



Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы